Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-05

FDA Approved: LAMIVUDINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for lamivudine, resulting in an approved generic lamivudine product. Lamivudine is used to treat HI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

SUPPL AP for LAMIVUDINE (LAMIVUDINE)